Astrazeneca Pharma India's Stock Sees Positive Trend, Outperforms Sector by 5.44%

Astrazeneca Pharma India, a midcap pharmaceutical company, has seen a positive trend in its stock performance on September 30, 2024. The stock gained 5.63%, outperforming the sector by 5.44%. This comes after three consecutive days of falling stock prices, indicating a potential trend reversal.

On the same day, Astrazeneca Pharma India's stock reached an intraday high of Rs 7661.7, showing a 6.63% increase. The company's stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong performance.

In comparison to the Sensex, Astrazeneca Pharma India's stock has outperformed with a 1-day performance of 7.38% while the Sensex's performance was -0.76%. Similarly, in the past month, the company's stock has shown a 16.85% increase, while the Sensex's performance was 3.11%.

MarketsMOJO has given a 'Hold' call for Astrazeneca Pharma India's stock, indicating a neutral stance. The company, which operates in the pharmaceutical and drugs industry, has shown promising performance in the market. Investors can keep an eye on this midcap company for potential growth opportunities.